Jun 30, 2023 9:28am EDT Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors
Jun 06, 2023 4:30pm EDT Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc.
Jun 01, 2023 7:57am EDT Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
May 03, 2023 8:26am EDT Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference
Mar 02, 2023 8:00am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting
Feb 23, 2023 8:00am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Feb 16, 2023 7:30am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award
Jan 18, 2023 8:00am EST Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004
